Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
dexamethasone intraocular suspension
|
| gptkbp:approvalYear |
2018
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
gptkb:S01BA01
|
| gptkbp:form |
suspension
|
| https://www.w3.org/2000/01/rdf-schema#label |
Dexycu
|
| gptkbp:indication |
postoperative inflammation
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
EyePoint Pharmaceuticals
|
| gptkbp:mechanismOfAction |
corticosteroid anti-inflammatory
|
| gptkbp:routeOfAdministration |
intraocular
|
| gptkbp:sideEffect |
eye pain
increased intraocular pressure corneal edema anterior chamber inflammation |
| gptkbp:usedFor |
cataract surgery
|
| gptkbp:bfsParent |
gptkb:Arbor_Pharmaceuticals
|
| gptkbp:bfsLayer |
8
|